Current progress of nanomedicine for prostate cancer diagnosis and treatment
Open Access
- 20 September 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 155, 113714
Abstract
No abstract availableKeywords
Funding Information
- Jilin Provincial Scientific and Technological Development Program (20210101272JC)
- Department of Finance of Jilin Province (2020SCZ44)
This publication has 193 references indexed in Scilit:
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study GroupJournal of Clinical Oncology, 2013
- Can nanotechnology potentiate photodynamic therapy?Nanotechnology Reviews, 2012
- Development of Regional Chemotherapies: feasibility, Safety and Efficacy in Clinical Use and Preclinical StudiesTherapeutic Delivery, 2011
- Cancer theranostics: the rise of targeted magnetic nanoparticlesTrends in Biotechnology, 2011
- Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2011
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold NanoparticlesClinical Cancer Research, 2010
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered ReleasePharmaceutical Research, 2010
- Time Trends and Local Variation in Primary Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2010
- Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapyExpert Opinion on Pharmacotherapy, 2002
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965